(Q43666939)

25 November 2017

title

Massive plasmocytosis due to methimazole-induced bone marrow toxicity (English)

1 reference

25 November 2017

Breier DV

1

1 reference

25 November 2017

Rendo P

2

1 reference

25 November 2017

Gonzalez J

3

1 reference

25 November 2017

Shilton G

4

1 reference

25 November 2017

Stivel M

5

1 reference

25 November 2017

Goldztein S

6

1 reference

25 November 2017

publication date

1 August 2001

1 reference

American Journal of Hematology

25 November 2017

published in

1 reference

25 November 2017

volume

67

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

259-261

1 reference

Adverse effects related to thionamide drugs and their dose regimen

25 November 2017

cites work

1 reference

Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor

21 January 2018

1 reference

Treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte-monocyte colony-stimulating factor and glucocorticosteroids

21 January 2018

1 reference

Successful treatment of methimazole-induced agranulocytosis by granulocyte colony-stimulating factor

21 January 2018

1 reference

Methimazole-induced agranulocytosis and granulocyte-colony stimulating factor

21 January 2018

1 reference

Adverse effects related to antithyroid drugs and their dose regimen

21 January 2018

1 reference

Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study

21 January 2018

1 reference

Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study

21 January 2018

1 reference

Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.1127

1 reference

25 November 2017

1 reference